Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression-Reference-Cited by-同舟云学术

Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression

Published:2016-11-08 Issue:49 Volume:7 Page:81156-81171
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

He Feng¹²,Chen Huacui¹,Yang Ping¹,Wu Qianlong¹,Zhang Tong¹,Wang Chengxing¹,Wei Jianchang¹,Chen Zhuanpeng¹,Hu He¹,Li Wanglin¹,Cao Jie¹

Affiliation:

1. Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China

2. Department of Pathology, Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, Connecticut 06520, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. POLR1D silencing suppresses lung cancer cells proliferation and migration via inhibition of PI3K-Akt pathway;Journal of Cardiothoracic Surgery;2024-06-06

2. Role of natural secondary metabolites as HIF-1 inhibitors in cancer therapy;Medicinal Chemistry Research;2024-05

3. Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells;Pathology - Research and Practice;2023-05

4. Novel biomarkers for neoplastic progression from ulcerative colitis to colorectal cancer: a systems biology approach;Scientific Reports;2023-02-28

5. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures;Cells;2023-01-09